Le Lézard
Classified in: Health
Subject: MRR

The US Laboratory Developed Tests (LDTs) Market to Contribute $3.08 Billion Revenue Share by 2029 - Personalized Medicines Boosting the Market Opportunities - Exclusive Focus Insight Report by Arizton


CHICAGO, May 8, 2024 /PRNewswire/ -- According to Arizton's latest focus insight report, the US laboratory developed tests market is growing at a CAGR of 3.40% from 2023 to 2029.

To Know More, Click: https://www.focusreports.store/report/us-laboratory-developed-tests-market

The U.S. Laboratory Developed Tests (LDTs) Market Report Scope

Report Attributes

Details

Market Size (2029)

USD 3.08 Billion

Market Size (2023)

USD 2.52 Billion

CAGR (2023-2029)

3.40 %

Historic Year?

2020-2022? 

Base Year?? 

2023

Forecast Year?? 

2024-2029? 


Personalized medicines are becoming the trademark of cancer treatment. It is a constantly evolving approach based on customized treatments based on individual genetic makeup. The FDA approved 12 personalized medications in 2019 to investigate and address the root causes of the diseases, thus combining precision medicine in clinical care. LDTs play a vital role in developing personalized medicine that are likely to prove promising means of tackling diseases through effective treatments. Biopharmaceutical companies have doubled their R&D investments in personalized drugs in the last few years, and they are further expected to increase their investments by 33% in the next five years. The rising demand for personalized medicine offers significant growth opportunities for the growth of the vendors operating in the laboratory developed tests market.

Key Points

Competitive Landscape

Intense competition characterizes the laboratory developed tests (LDTs) market, driven by manufacturers and developers striving for innovation and distinctiveness. Among the approximately 267,000 lab facilities in the US, only 12,000 CLIA certified laboratories can develop and utilize LDTs. Furthermore, the expansion of operations by health system laboratories has increased competition for clinical laboratory testing from physicians within these health systems and unaffiliated physicians in their service areas. Investment and innovation in the Laboratory Developed Test (LDT) sector are on the rise, driven by the improving precision and efficacy of these tests in disease detection and diagnosis. Major independent laboratories such as LabCorp and Quest Diagnostics are significant players in the US market, alongside several international independent clinical laboratories competing with smaller domestic vendors. Notable competitors in the US clinical laboratory tests market include LabCorp, Quest Diagnostics, Sonic Healthcare, and OPKO Health.

To Know More, Click: https://www.focusreports.store/report/us-laboratory-developed-tests-market

Segmentation & Forecast

Vendors List

Key Questions Answered in the Report:

Q. How big is the U.S. laboratory developed tests market?
Q What is the growth rate of the U.S. laboratory developed tests market?
Q. What are the key trends in the U.S. laboratory developed tests (LDTs) market?

Table of Content

CHAPTER ? 1: Laboratory Developed Tests Market Overview

CHAPTER ? 2: Laboratory Developed Tests Market

CHAPTER ? 3: Laboratory Developed Tests Market Segmentation Data

CHAPTER ? 4: Laboratory Developed Tests Market Prospects & Opportunities

CHAPTER ? 5: Laboratory Developed Tests Industry Overview

CHAPTER ? 6: Appendix

About Focused Reports by Arizton????????? 

Welcome to Focused Reports, an esteemed Arizton Advisory & Intelligence subsidiary committed to delivering precise and insightful market research reports across all key geographies. Our unique selling proposition lies in our affordable pricing, accurate data, in-depth research, and presentation-ready reports. With us, expensive market research is a thing of the past. We aim to be strategic, providing valuable data. Focus Reports is where folks come to name their ideas, create a compelling brand and a great-looking website, and attract customers with digital and social marketing.?? 

About Us:????????????????????????????????????????????????????????? 

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.???????????????????????????????????????????????????????????? 

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.????????????????????????????????????????????????????????????? 

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.????????? 

Contact Us:?????????
Call: +1-312-235-2040??????????????????????????????????????????????????? 
????????? +1 302 469 0707????????????????????????????????????????????????? 
Mail: [email protected]????????
Website: https://www.focusreports.store/

Photo: https://mma.prnewswire.com/media/2407699/Aritzon_Laboratory_Tests_Market_Infographic.jpg
Link: https://mma.prnewswire.com/media/2326840/4694489/Focus_Reports_Logo.jpg

 

SOURCE Arizton Advisory & Intelligence


These press releases may also interest you

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 12:18
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...



News published on and distributed by: